#xiayu — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #xiayu, aggregated by home.social.
-
China’s Akeso says cancer drug beat AstraZeneca’s Imfinzi in phase 3 trial
Chinese biopharmaceutical firm Akeso announced on Wednesday that its immunotherapy drug had outperformed AstraZeneca’s Imfinzi in a head-to-head…
#EuropeSays #Britain #Europe #EU #AstraZeneca #Akeso #biliarytractcancer #China #durvalumab #HangSengindex #HongKong #HongKongStockExchange #Imfinzi #ivonescimab #MacquarieCapital #Nature #Nomura #XiaYu #ZhangJialin
https://www.europesays.com/britain/112272/ -
https://www.europesays.com/britain/112272/ China’s Akeso says cancer drug beat AstraZeneca’s Imfinzi in phase 3 trial #Akeso #AstraZeneca #BiliaryTractCancer #China #durvalumab #HangSengIndex #HongKong #HongKongStockExchange #Imfinzi #ivonescimab #MacquarieCapital #Nature #Nomura #XiaYu #ZhangJialin
-
China’s Akeso says cancer drug beat AstraZeneca’s Imfinzi in phase 3 trial
Chinese biopharmaceutical firm Akeso announced on Wednesday that its immunotherapy drug had outperformed AstraZeneca’s Imfinzi in a head-to-head…
#EuropeSays #Britain #Europe #EU #AstraZeneca #Akeso #biliarytractcancer #China #durvalumab #HangSengindex #HongKong #HongKongStockExchange #Imfinzi #ivonescimab #MacquarieCapital #Nature #Nomura #XiaYu #ZhangJialin
https://www.europesays.com/britain/111906/ -
https://www.europesays.com/britain/111906/ China’s Akeso says cancer drug beat AstraZeneca’s Imfinzi in phase 3 trial #Akeso #AstraZeneca #BiliaryTractCancer #China #durvalumab #HangSengIndex #HongKong #HongKongStockExchange #Imfinzi #ivonescimab #MacquarieCapital #Nature #Nomura #XiaYu #ZhangJialin